Keywords: Actavis, QRxPharma, MoxDuo, Pain drug, USA

Actavis in deal with QRxPharma for novel pain drug

Article | 21 December 2011

Print This

Iceland-headquartered generics major Actavis Group, via its US subsidiary, has entered into a binding letter of intent with Australian firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in